Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Alaunos Therapeutics Inc (TCRT)

  • Technical Exchange News
  • Feb. 16, 2024, 19:03 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Novo Integrated Sciences Inc (NVOS)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

GeoVax Labs Inc. (GOVX)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

BIOLASE Inc (BIOL)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 28
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

AlloVir Inc (ALVR)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 29
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Vaxxinity Inc. (VAXX)

  • Technical Exchange News
  • Feb. 16, 2024, 18:45 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Alaunos Therapeutics Inc (TCRT)

  • Technical Exchange News
  • Feb. 16, 2024, 18:45 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Novo Integrated Sciences Inc (NVOS)

  • Technical Exchange News
  • Feb. 16, 2024, 18:45 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Technical Exchange News
  • Feb. 16, 2024, 18:45 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 680
  • 681
  • 682
  • 683
  • 684
  • Next

Search

News categories

  • Technical Exchange News(10967)
  • Event(2433)
  • SEC News(193218)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125804)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin